In 2025, Resmed completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).
However, Resmed has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2025 | 2024 | 2023 | 2022 - 2017 |
|---|---|---|---|---|
Total Scope 1 | 0000000 | Copy/Paste is a PRO feature. | Copy/Paste is a PRO feature. | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | Copy/Paste is a PRO feature. | 0000000 | Copy/Paste is a PRO feature. | 0000000 |
Total Scope 3 | Copy/Paste is a PRO feature. | Copy/Paste is a PRO feature. | 0000000 | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | 0000000 | Copy/Paste is a PRO feature. | Copy/Paste is a PRO feature. | 0000000 |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Resmed’s data sources below and access millions more through our Disclosure Search.
In 2025, the total operational greenhouse gas (GHG) emissions of Resmed amounted to 27,530 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a
Compared to 2024, the total operational greenhouse gas (GHG) emissions of Resmed decreased by 3.94%, showing that the company has made progress in taking action to reduce the climate impact of its operations.a
In 2025, the total Scope 1 emissions of Resmed were 3,957 metric tons of CO₂ equivalent (tCO₂e).a
Since 2021, Resmed's Scope 1 emissions have increased by 63.65%, reflecting a rising long-term trend in Scope 1 emissions over time.ab
Compared to the previous year (2024), Resmed's Scope 1 emissions decreased by 6.59%, highlighting the company's efforts to lower direct emissions from assets it owns or controls.a
In 2025, Resmed reported Scope 2 greenhouse gas (GHG) emissions of 23,573 tCO₂e without specifying the calculation method.a
Since 2021, Resmed's Scope 2 greenhouse gas (GHG) emissions (Unspecified Calculation Method) have remained relatively stable, indicating that Resmed's emissions have plateaued with no significant change in its energy consumption footprint.ab
Compared to the previous year (2024), Resmed's Scope 2 emissions (Unspecified Calculation Method) have remained relatively stable, indicating that Resmed's emissions have plateaued with no significant change in its energy consumption footprint.a
In 2025, Resmed reported its Scope 2 emissions using an unspecified methodology.a
In 2025, Resmed reported Scope 1 greenhouse gas (GHG) emissions of 3,957 tCO₂e and total revenues of USD 5,146 millions. This translates into an emissions intensity of 0.77 tCO₂e per millions USD.a
In 2025, Resmed reported a Scope 1 emissions intensity of 0.77 tCO₂e per millions USD. Compared to the peer group median of 5.49, this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors.a
In 2025, Resmed ranked 1 out of 24 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD).a
This places Resmed among the top performers, with one of the lowest emissions intensities relative to peers.a